Inhibition	O
of	O
NF-AT	B-protein
-dependent	O
transcription	O
by	O
NF-kappa	B-protein
B	I-protein
:	O
implications	O
for	O
differential	O
gene	O
expression	O
in	O
T	B-cell_type
helper	I-cell_type
cell	I-cell_type
subsets	I-cell_type
.	O

Activation	O
of	O
individual	O
CD4+	B-cell_line
T	I-cell_line
cells	I-cell_line
results	O
in	O
differential	O
lymphokine	B-protein
expression	O
:	O
interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
is	O
preferentially	O
produced	O
by	O
T	B-cell_line
helper	I-cell_line
type	I-cell_line
1	I-cell_line
(	I-cell_line
TH1	I-cell_line
)	I-cell_line
cells	I-cell_line
,	O
which	O
are	O
involved	O
in	O
cell-mediated	O
immune	O
responses	O
,	O
whereas	O
IL-4	B-protein
is	O
synthesized	O
by	O
TH2	B-cell_line
cells	I-cell_line
,	O
which	O
are	O
essential	O
for	O
humoral	O
immunity	O
.	O

The	O
Ca	B-protein
(	I-protein
2+	I-protein
)	I-protein
-dependent	I-protein
factor	I-protein
NF-ATp	B-protein
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
transcription	O
of	O
both	O
these	O
lymphokine	B-DNA
genes	I-DNA
.	O

However	O
,	O
while	O
IL2	B-protein
expression	O
requires	O
the	O
contribution	O
of	O
Ca	O
(	O
2+	O
)	O
-	O
and	O
protein	B-protein
kinase	I-protein
C	I-protein
-dependent	O
signals	O
,	O
we	O
report	O
that	O
activation	O
of	O
human	B-protein
IL4	I-protein
transcription	O
through	O
the	O
Ca	O
(	O
2+	O
)	O
-dependent	O
pathway	O
is	O
diminished	O
by	O
protein	B-protein
kinase	I-protein
C	I-protein
stimulation	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

This	O
phenomenon	O
is	O
due	O
to	O
mutually	O
exclusive	O
binding	O
of	O
NF-ATp	B-protein
and	O
NF-kappa	B-protein
B	I-protein
to	O
the	O
P	B-DNA
sequence	I-DNA
,	O
an	O
element	O
located	O
69	B-DNA
bp	I-DNA
upstream	I-DNA
of	O
the	O
IL4	B-DNA
transcription	I-DNA
initiation	I-DNA
site	I-DNA
.	O

Human	B-DNA
IL4	I-DNA
promoter	I-DNA
-mediated	O
transcription	O
is	O
downregulated	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
stimulated	O
with	O
the	O
NF-kappa	B-protein
B-activating	I-protein
cytokine	I-protein
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
and	O
suppressed	O
in	O
RelA-overexpressing	B-cell_line
cells	I-cell_line
.	O

In	O
contrast	O
,	O
protein	B-protein
kinase	I-protein
C	I-protein
stimulation	O
or	O
RelA	B-protein
overexpression	O
does	O
not	O
affect	O
the	O
activity	O
of	O
a	O
human	B-DNA
IL4	I-DNA
promoter	I-DNA
containing	O
a	O
mouse	B-DNA
P	I-DNA
sequence	I-DNA
,	O
which	O
is	O
a	O
higher-affinity	B-DNA
site	I-DNA
for	O
NF-ATp	B-protein
and	O
a	O
lower-affinity	B-DNA
site	I-DNA
for	O
RelA	B-protein
.	O

Thus	O
,	O
competition	O
between	O
two	O
general	O
transcriptional	B-protein
activators	I-protein
,	O
RelA	B-protein
and	O
NF-ATp	B-protein
,	O
mediates	O
the	O
inhibitory	O
effect	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
stimulation	O
on	O
IL4	B-protein
expression	O
and	O
may	O
contribute	O
to	O
differential	O
gene	O
expression	O
in	O
TH	B-cell_line
cells	I-cell_line
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

92	NULL
,	NULL
pp	NULL
.	NULL

11623-11627	NULL
,	NULL
December	NULL
1995	NULL
Immunology	NULL
Inhibition	NULL
of	NULL
NF-AT-dependent	NULL
transcription	NULL
by	NULL
NF-KB	NULL
:	NULL
Implications	NULL
for	NULL
differential	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
(	NULL
interleukin	NULL
2/interleukin	NULL
4/protein	NULL
kinase	NULL
C/tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
)	NULL
Vincenzo	NULL
CasoLarRo*	NULL
,	NULL
STEVE	NULL
N.	NULL
GEoRas*	NULL
,	NULL
ZnimiIn	NULL
SoNG*	NULL
,	NULL
Ira	NULL
D.	NULL
ZUBKOFF*	NULL
,	NULL
SARKI	NULL
A.	NULL
ABDULKADIR*	NULL
,	NULL
DmiitRIs	NULL
THanost	NULL
,	NULL
AND	NULL
Santa	NULL
Jeremy	NULL
Ono*t§	NULL
Departments	NULL
of	NULL
*Medicine	NULL
and	NULL
*Pathology	NULL
and	NULL
Biology	NULL
,	NULL
Graduate	NULL
Program	NULL
in	NULL
Immunology	NULL
and	NULL
The	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Graduate	NULL
Program	NULL
in	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Medicine	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
5501	NULL
Hopkins	NULL
Bayview	NULL
Circle	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21224	NULL
;	NULL
'Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
7	NULL
Divinity	NULL
Avenue	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02138	NULL
Communicated	NULL
by	NULL
Tom	NULL
Maniatis	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
,	NULL
July	NULL
25	NULL
,	NULL
1995	NULL
(	NULL
received	NULL
for	NULL
review	NULL
February	NULL
24	NULL
,	NULL
1995	NULL
)	NULL
ABSTRACT	NULL
Activation	NULL
of	NULL
individual	NULL
CD4*	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
differential	NULL
lymphokine	NULL
expression	NULL
:	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
is	NULL
preferentially	NULL
produced	NULL
by	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Ty1	NULL
)	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
,	NULL
whereas	NULL
IL-4	NULL
is	NULL
synthesized	NULL
by	NULL
Ty2	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
essential	NULL
for	NULL
humoral	NULL
immunity	NULL
,	NULL
The	NULL
Ca++-dependent	NULL
factor	NULL
NF-AT	NULL
,	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
inducible	NULL
transcription	NULL
of	NULL
both	NULL
these	NULL
lymphokine	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
while	NULL
IL2	NULL
expression	NULL
requires	NULL
the	NULL
contribution	NULL
of	NULL
Ca*+*-	NULL
and	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
signals	NULL
,	NULL
we	NULL
report	NULL
that	NULL
activation	NULL
of	NULL
human	NULL
IL4	NULL
transcription	NULL
through	NULL
the	NULL
Ca*+-dependent	NULL
pathway	NULL
is	NULL
diminished	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
stimulation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
phenomenon	NULL
is	NULL
due	NULL
to	NULL
mutually	NULL
exclusive	NULL
binding	NULL
of	NULL
NF-AT	NULL
,	NULL
,	NULL
and	NULL
NF-xB	NULL
to	NULL
the	NULL
P	NULL
sequence	NULL
,	NULL
an	NULL
element	NULL
located	NULL
69	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
IL4	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Human	NULL
ZIL4	NULL
promoter-mediated	NULL
transcription	NULL
is	NULL
downregulated	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-activating	NULL
cytokine	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
suppressed	NULL
in	NULL
RelA-overexpressing	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
stimulation	NULL
or	NULL
RelA	NULL
overexpression	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
human	NULL
ZL	NULL
4	NULL
promoter	NULL
containing	NULL
a	NULL
mouse	NULL
P	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
a	NULL
higher-affinity	NULL
site	NULL
for	NULL
NF-AT	NULL
,	NULL
and	NULL
a	NULL
lower-affinity	NULL
site	NULL
for	NULL
RelA	NULL
.	NULL

Thus	NULL
,	NULL
competition	NULL
between	NULL
two	NULL
general	NULL
transcriptional	NULL
activators	NULL
,	NULL
RelA	NULL
and	NULL
NF-AT	NULL
,	NULL
,	NULL
mediates	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
stimulation	NULL
on	NULL
IL4	NULL
expression	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
differential	NULL
gene	NULL
expression	NULL
in	NULL
Ty	NULL
cells	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
distinct	NULL
lymphokine	NULL
profiles	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
has	NULL
led	NULL
to	NULL
the	NULL
definition	NULL
of	NULL
two	NULL
functional	NULL
subpopulations	NULL
in	NULL
rodents	NULL
and	NULL
in	NULL
man	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
:	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Tl	NULL
)	NULL
cell	NULL
clones	NULL
synthesize	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
interferon	NULL
y	NULL
and	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
cell-mediated	NULL
responses	NULL
,	NULL
whereas	NULL
Ty2	NULL
clones	NULL
,	NULL
producing	NULL
IL-4	NULL
and	NULL
IL-5	NULL
among	NULL
others	NULL
,	NULL
generally	NULL
provide	NULL
help	NULL
for	NULL
humoral	NULL
immunity	NULL
and	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
development	NULL
of	NULL
inflammatory	NULL
reactions	NULL
.	NULL

Central	NULL
to	NULL
this	NULL
notion	NULL
is	NULL
the	NULL
role	NULL
of	NULL
individual	NULL
lymphokines	NULL
that	NULL
in	NULL
turn	NULL
regulate	NULL
Ty1/Ty2	NULL
cell	NULL
differentiation	NULL
and	NULL
function	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
implicate	NULL
a	NULL
role	NULL
for	NULL
differential	NULL
signaling	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
Ty1l-	NULL
and	NULL
Ty2-related	NULL
lymphokines	NULL
(	NULL
4-7	NULL
)	NULL
.	NULL

IL2	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
concomitant	NULL
activation	NULL
of	NULL
Ca*+*+-	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
-dependent	NULL
pathways	NULL
(	NULL
4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
while	NULL
triggering	NULL
of	NULL
Ca**-mediated	NULL
signals	NULL
is	NULL
sufficient	NULL
for	NULL
maximal	NULL
ZL	NULL
4	NULL
transcription	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
IL-4	NULL
secretion	NULL
from	NULL
human	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
downregulated	NULL
following	NULL
PKC	NULL
stimulation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
diverging	NULL
effects	NULL
of	NULL
PKC	NULL
on	NULL
IL2	NULL
and	NULL
IL4	NULL
expression	NULL
are	NULL
presumably	NULL
exerted	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

The	NULL
Ca	NULL
*-	NULL
and	NULL
calcineurin-dependent	NULL
factor	NULL
NF-AT	NULL
,	NULL
(	NULL
8	NULL
)	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
of	NULL
these	NULL
lymphokine	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

11623	NULL
genes	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

NF-AT	NULL
,	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
maximal	NULL
IL4	NULL
promoter	NULL
activity	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
whereas	NULL
IL2	NULL
transcription	NULL
also	NULL
requires	NULL
the	NULL
involvement	NULL
of	NULL
PKC-dependent	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
possible	NULL
molecular	NULL
mechanisms	NULL
leading	NULL
to	NULL
mutually	NULL
exclusive	NULL
lymphokine	NULL
expression	NULL
in	NULL
Ty	NULL
cells	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL2	NULL
and	NULL
IL4	NULL
promoter-driven	NULL
reporter	NULL
genes	NULL
in	NULL
the	NULL
human	NULL
T	NULL
lymphoid	NULL
cell	NULL
line	NULL
Jurkat	NULL
stimulated	NULL
with	NULL
a	NULL
Ca*+*-agonist	NULL
and/or	NULL
a	NULL
PKC	NULL
agonist	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
PKC	NULL
stimulation	NULL
inhibits	NULL
human	NULL
IL4	NULL
transcription	NULL
,	NULL
which	NULL
is	NULL
,	NULL
surprisingly	NULL
,	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
the	NULL
general	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
positive	NULL
regulatory	NULL
P	NULL
sequence	NULL
(	NULL
14	NULL
)	NULL
.	NULL

NF-kB	NULL
may	NULL
,	NULL
therefore	NULL
,	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
Ty	NULL
]	NULL
/Tn2	NULL
differentiation	NULL
through	NULL
a	NULL
mechanism	NULL
of	NULL
competitive	NULL
repression	NULL
of	NULL
NF-AT-dependent	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Construction	NULL
and	NULL
Transfections	NULL
.	NULL

L4	NULL
promoter	NULL
fragments	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
Xba	NULL
I	NULL
sites	NULL
of	NULL
pCAT-Basic	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
construct	NULL
the	NULL
reporter	NULL
plasmids	NULL
pIL-4.741	NULL
,	NULL
pIL-4.306	NULL
,	NULL
pIL-4.95	NULL
,	NULL
and	NULL
pIL-4.65	NULL
.	NULL

The	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
and	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
insertion	NULL
into	NULL
pCAT-Basic	NULL
of	NULL
PCR	NULL
products	NULL
generated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
pIL-4.95	NULL
.	NULL

The	NULL
IL-2.15ACX	NULL
reporter	NULL
plasmid	NULL
and	NULL
the	NULL
RelA	NULL
and	NULL
NFKBI1	NULL
expression	NULL
plasmids	NULL
have	NULL
been	NULL
described	NULL
(	NULL
9	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
48-hr	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
Lipofectamine	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
2.4-5.2	NULL
mg/ml	NULL
and	NULL
were	NULL
stimulated	NULL
16-18	NULL
hr	NULL
before	NULL
harvest	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
was	NULL
assayed	NULL
in	NULL
cell	NULL
lysates	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Recombinant	NULL
Proteins	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Recombinant	NULL
NF-ATpXS	NULL
(	NULL
1-297	NULL
)	NULL
was	NULL
expressed	NULL
in	NULL
bacteria	NULL
as	NULL
a	NULL
hexahisti-dine-tagged	NULL
protein	NULL
and	NULL
extracted	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
procedure	NULL
for	NULL
bacterial	NULL
expression	NULL
and	NULL
purification	NULL
of	NULL
RelA	NULL
and	NULL
NFKB1	NULL
proteins	NULL
has	NULL
been	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility-Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
and	NULL
their	NULL
complements	NULL
were	NULL
used	NULL
:	NULL
5'-GTGTAACGAAAATTTCCAATGTAAAC-3	NULL
'	NULL
(	NULL
human	NULL
P	NULL
sequence	NULL
,	NULL
huP	NULL
)	NULL
(	NULL
14	NULL
)	NULL
and	NULL
5-GTGTAATAAAATTTTCCA-ATGTAAAC-3	NULL
'	NULL
(	NULL
mouse	NULL
P	NULL
sequence	NULL
,	NULL
muP	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Free	NULL
probes	NULL
and	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
4	NULL
%	NULL
PAGE	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PRD	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
;	NULL
Ty1	NULL
and	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
and	NULL
2	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

11624	NULL
_	NULL
Immunology	NULL
:	NULL
Casolaro	NULL
et	NULL
al	NULL
.	NULL

For	NULL
Scatchard	NULL
analysis	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
bound	NULL
and	NULL
free	NULL
DNA	NULL
were	NULL
determined	NULL
by	NULL
excision	NULL
and	NULL
liquid	NULL
scintillation	NULL
counting	NULL
of	NULL
the	NULL
corresponding	NULL
gel	NULL
fragments	NULL
(	NULL
20	NULL
)	NULL
.	NULL

RESULTS	NULL
PKC	NULL
Stimulation	NULL
Downregulates	NULL
IL4	NULL
Promoter	NULL
Activity	NULL
.	NULL

We	NULL
compared	NULL
CAT	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
human	NULL
IL2	NULL
and	NULL
IL4	NULL
promoters	NULL
(	NULL
9	NULL
,	NULL
14	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
the	NULL
Ca*+*	NULL
ionophore	NULL
A23187	NULL
(	NULL
0.5	NULL
uM	NULL
)	NULL
and/or	NULL
the	NULL
PKC	NULL
agonist	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
``	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
,	NULL
``	NULL
TPA	NULL
)	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
(	NULL
4	NULL
,	NULL
9	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
IL2	NULL
promoter	NULL
required	NULL
treatment	NULL
with	NULL
both	NULL
agents	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

In	NULL
striking	NULL
contrast	NULL
,	NULL
IL4	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
,	NULL
as	NULL
described	NULL
(	NULL
10	NULL
,	NULL
21	NULL
)	NULL
,	NULL
maximally	NULL
stimulated	NULL
by	NULL
A23187	NULL
,	NULL
was	NULL
inhibited	NULL
by	NULL
concomitant	NULL
treatment	NULL
with	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

By	NULL
use	NULL
of	NULL
a	NULL
series	NULL
of	NULL
5'-deletion	NULL
reporter	NULL
constructs	NULL
,	NULL
this	NULL
effect	NULL
of	NULL
TPA	NULL
was	NULL
mapped	NULL
to	NULL
a	NULL
region	NULL
spanning	NULL
bp	NULL
-95	NULL
to	NULL
-65	NULL
relative	NULL
to	NULL
the	NULL
ZL4	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
the	NULL
P	NULL
sequence	NULL
,	NULL
an	NULL
11-bp	NULL
element	NULL
(	NULL
~CGAAAATTTCC-®	NULL
)	NULL
originally	NULL
characterized	NULL
as	NULL
mediating	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
IL4	NULL
promoter	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Up	NULL
to	NULL
five	NULL
similar	NULL
elements	NULL
have	NULL
been	NULL
described	NULL
in	NULL
the	NULL
mouse	NULL
IL4	NULL
promoter	NULL
sharing	NULL
the	NULL
consensus	NULL
sequence	NULL
ATTTTCCNNT	NULL
and	NULL
binding	NULL
the	NULL
transcriptional	NULL
complex	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

NF-xB	NULL
Binds	NULL
to	NULL
the	NULL
P	NULL
Sequence	NULL
upon	NULL
PKC	NULL
Stimulation	NULL
.	NULL

To	NULL
identify	NULL
possible	NULL
factors	NULL
mediating	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PKC	NULL
on	NULL
IL4	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
analyzed	NULL
complex	NULL
formation	NULL
on	NULL
a	NULL
human	NULL
P	NULL
sequence	NULL
probe	NULL
in	NULL
EMSAs	NULL
using	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
A23187	NULL
(	NULL
0.5	NULL
wM	NULL
)	NULL
and/or	NULL
TPA	NULL
(	NULL
20	NULL
A	NULL
10	NULL
C	NULL
Control	NULL
g	NULL
-	NULL
®	NULL
TPA	NULL
&	NULL
&	NULL
]	NULL
A23187	NULL
2	NULL
=	NULL
A23187/TPA	NULL
Nud	NULL
0	NULL
53	NULL
``	NULL
C	NULL
&	NULL
m	NULL
3	NULL
LL	NULL
,	NULL
IL-2	NULL
.	NULL

15ACX	NULL
pIL-4.306	NULL
B	NULL
Fold	NULL
Induction	NULL
0	NULL
0	NULL
4	NULL
2.	NULL
v8	NULL
``	NULL
4.0	NULL
.	NULL

B	NULL
Cpica741	NULL
pIL-4.306	NULL
pIL-4.95	NULL
‘	NULL
A	NULL
CJ	NULL
Control	NULL
pit-4:86	NULL
a	NULL
5212307	NULL
E	NULL
A23187TPA	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Downregulation	NULL
of	NULL
IL4	NULL
promoter	NULL
activity	NULL
by	NULL
PKC	NULL
.	NULL

(	NULL
4	NULL
)	NULL
A	NULL
reporter	NULL
plasmid	NULL
,	NULL
IL-2.15ACX	NULL
or	NULL
pIL-4.306	NULL
,	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
A23187	NULL
and/or	NULL
TPA	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
six	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
reporter	NULL
plasmids	NULL
pIL-4.741	NULL
,	NULL
pIL-4.306	NULL
,	NULL
pIL-4.95	NULL
,	NULL
and	NULL
pIL-4.65	NULL
,	NULL
bearing	NULL
5	NULL
'	NULL
deletions	NULL
to	NULL
the	NULL
indicated	NULL
nucleotide	NULL
of	NULL
human	NULL
IL4	NULL
.	NULL

The	NULL
relative	NULL
location	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
is	NULL
indicated	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
(	NULL
pIL-4.741	NULL
and	NULL
pIL-4.65	NULL
)	NULL
or	NULL
six	NULL
(	NULL
pIL-4.306	NULL
and	NULL
pIL-4.95	NULL
)	NULL
independent	NULL
transfections	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
ng/ml	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
11	NULL
,	NULL
14	NULL
)	NULL
,	NULL
a	NULL
se-quence-specific	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
complex	NULL
formed	NULL
with	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
enhanced	NULL
by	NULL
treatment	NULL
with	NULL
A23187	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
cotreat-ment	NULL
with	NULL
TPA	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
additional	NULL
complex	NULL
of	NULL
higher	NULL
mobility	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
was	NULL
inhibited	NULL
when	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
from	NULL
the	NULL
mouse	NULL
«	NULL
-chain	NULL
enhancer	NULL
(	NULL
IgxB	NULL
)	NULL
(	NULL
22	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
(	NULL
AP-3	NULL
)	NULL
(	NULL
23	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

However	NULL
,	NULL
in	NULL
EMSAs	NULL
using	NULL
specific	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
complex	NULL
was	NULL
found	NULL
to	NULL
contain	NULL
NF-AT	NULL
,	NULL
and/or	NULL
antigenically	NULL
related	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
antisera	NULL
specific	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
components	NULL
RelA	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
NFKB1	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
interfered	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
TPA-inducible	NULL
complex	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
finding	NULL
,	NULL
the	NULL
two	NULL
complexes	NULL
will	NULL
be	NULL
referred	NULL
to	NULL
as	NULL
``	NULL
NF-AT	NULL
``	NULL
and	NULL
``	NULL
NF-kB	NULL
``	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
NF-AT	NULL
complex	NULL
can	NULL
be	NULL
resolved	NULL
into	NULL
two	NULL
discrete	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
which	NULL
are	NULL
,	NULL
however	NULL
,	NULL
similar	NULL
to	NULL
each	NULL
other	NULL
for	NULL
sequence	NULL
specificity	NULL
and	NULL
immunoreactivity	NULL
and	NULL
presumably	NULL
contain	NULL
distinct	NULL
NF-ATp-related	NULL
molecular	NULL
species	NULL
(	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
additional	NULL
``	NULL
high-mobility	NULL
complexes	NULL
``	NULL
(	NULL
HMC	NULL
)	NULL
(	NULL
14	NULL
)	NULL
of	NULL
unclear	NULL
specificity	NULL
,	NULL
whose	NULL
formation	NULL
is	NULL
not	NULL
apparently	NULL
affected	NULL
by	NULL
cell	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
10	NULL
,	NULL
25	NULL
)	NULL
,	NULL
none	NULL
of	NULL
the	NULL
complexes	NULL
described	NULL
appeared	NULL
to	NULL
contain	NULL
AP-1-related	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

IL4	NULL
Promoter	NULL
Activity	NULL
Is	NULL
Repressed	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Thus	NULL
,	NULL
PKC-mediated	NULL
downregulation	NULL
of	NULL
human	NULL
IL4	NULL
transcription	NULL
is	NULL
paralleled	NULL
by	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
alternative	NULL
complex	NULL
,	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
on	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF-a	NULL
,	NULL
20	NULL
ng/ml	NULL
)	NULL
,	NULL
which	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
inducing	NULL
proteolysis	NULL
of	NULL
the	NULL
inhibitor	NULL
protein	NULL
IxBa	NULL
(	NULL
26	NULL
)	NULL
,	NULL
substantially	NULL
decreased	NULL
A23187-induced	NULL
IL4	NULL
promoter	NULL
activity	NULL
while	NULL
increasing	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
IL2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
cotransfection	NULL
with	NULL
a	NULL
RelA	NULL
expression	NULL
plasmid	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
NFKB1	NULL
(	NULL
15	NULL
)	NULL
,	NULL
decreased	NULL
IL4	NULL
transcription	NULL
by	NULL
80	NULL
%	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
while	NULL
not	NULL
affecting	NULL
or	NULL
moderately	NULL
increasing	NULL
IL2	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
was	NULL
surprising	NULL
since	NULL
RelA	NULL
,	NULL
either	NULL
as	NULL
a	NULL
homodimer	NULL
or	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
NFKB1	NULL
(	NULL
20	NULL
)	NULL
,	NULL
usually	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
mammalian	NULL
genes	NULL
(	NULL
27	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
overexpression	NULL
of	NULL
NFKB1	NULL
alone	NULL
resulted	NULL
in	NULL
increased	NULL
IL4	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggested	NULL
that	NULL
NF-AT	NULL
displacement	NULL
from	NULL
the	NULL
P	NULL
sequence	NULL
by	NULL
RelA	NULL
could	NULL
be	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
TPA	NULL
and	NULL
TNF-a	NULL
repress	NULL
Ca**-mediated	NULL
IL4	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
view	NULL
,	NULL
NF-AT	NULL
complex	NULL
formation	NULL
was	NULL
consistently	NULL
decreased	NULL
by	NULL
coincubation	NULL
of	NULL
a	NULL
P-sequence	NULL
probe	NULL
with	NULL
recombinant	NULL
RelA	NULL
(	NULL
15	NULL
)	NULL
and	NULL
either	NULL
crude	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
a	NULL
recombinant	NULL
NF-AT	NULL
,	NULL
fragment-NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
-including	NULL
the	NULL
minimal	NULL
region	NULL
required	NULL
for	NULL
specific	NULL
DNA	NULL
binding	NULL
(	NULL
18	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
recombinant	NULL
RelA-NFKB1	NULL
heterodimers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
NFKB1	NULL
homodimers	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

The	NULL
Mouse	NULL
P	NULL
Sequence	NULL
Is	NULL
a	NULL
Lower-Affinity	NULL
Binding	NULL
Site	NULL
for	NULL
NF-xB	NULL
.	NULL

In	NULL
recent	NULL
studies	NULL
of	NULL
mouse	NULL
IL4	NULL
,	NULL
TPA	NULL
did	NULL
not	NULL
affect	NULL
promoter	NULL
activity	NULL
(	NULL
10	NULL
,	NULL
21	NULL
)	NULL
and	NULL
did	NULL
not	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
formation	NULL
on	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
P	NULL
sequences	NULL
differ	NULL
by	NULL
two	NULL
potentially	NULL
critical	NULL
nucleotides	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
:	NULL
(	NULL
?	NULL
)	NULL

an	NULL
A	NULL
-	NULL
>	NULL
G	NULL
transition	NULL
in	NULL
position	NULL
-78	NULL
makes	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
more	NULL
similar	NULL
to	NULL
a	NULL
consensus	NULL
NF-KB	NULL
site	NULL
,	NULL
such	NULL
as	NULL
PRD-II	NULL
of	NULL
the	NULL
interferon-B	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
,	NULL
the	NULL
highest-affinity	NULL
site	NULL
known	NULL
for	NULL
RelA	NULL
homodimers	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
(	NULL
#	NULL
)	NULL
an	NULL
A	NULL
to	NULL
T	NULL
transversion	NULL
in	NULL
position	NULL
-74	NULL
makes	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
more	NULL
similar	NULL
to	NULL
other	NULL
NF-AT	NULL
,	NULL
-binding	NULL
sites	NULL
,	NULL
such	NULL
as	NULL
the	NULL
mouse	NULL
IL2	NULL
distal	NULL
NF-AT	NULL
site	NULL
(	NULL
29	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
possible	NULL
impact	NULL
of	NULL
these	NULL
divergences	NULL
,	NULL
oligonucleotides	NULL
including	NULL
a	NULL
mouse	NULL
or	NULL
human	NULL
P	NULL
sequence	NULL
were	NULL
generated	NULL
for	NULL
use	NULL
in	NULL
EMSAs	NULL
with	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
A23187	NULL
and	NULL
TPA	NULL
.	NULL

Two	NULL
complexes	NULL
of	NULL
similar	NULL
mobility	NULL
and	NULL
immunoreactivity	NULL
Immunology	NULL
:	NULL
Casolaro	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
-	NULL
11625	NULL
C	NULL
a	NULL
n	NULL
assist	NULL
-+	NULL
+08	NULL
a	NULL
f26	NULL
&	NULL
°C	NULL
f	NULL
x	NULL
€	NULL
.	NULL

,	NULL
TPA	NULL
-	NULL
-	NULL
+	NULL
-	NULL
4	NULL
x	NULL
J	NULL
¢	NULL
0	NULL
Q	NULL
'	NULL
é	NULL
‘	NULL
é	NULL
’	NULL
é	NULL
‘	NULL
h	NULL
?	NULL

a	NULL
'	NULL
$	NULL
$	NULL
$	NULL
¢	NULL
-	NULL
>	NULL
WM	NULL
'	NULL
2:3	NULL
.	NULL

``	NULL
I	NULL
NF-AT	NULL
tulad	NULL
task	NULL
n.S	NULL
.	NULL

_	NULL
.	NULL

#	NULL
#	NULL
NF-	NULL
«	NULL
B	NULL
n.s	NULL
.	NULL

HMC-1I	NULL
i	NULL
mine	NULL
Chal	NULL
an	NULL
HMC-1	NULL
_	NULL
®	NULL
HMC-I1	NULL
Free	NULL
u	NULL
Free	NULL
Free	NULL
1:2	NULL
$	NULL
1.02	NULL
3.4	NULL
5.06	NULL
7	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
TPA-induced	NULL
NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
hr	NULL
with	NULL
A23187	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
with	NULL
A23187	NULL
and	NULL
TPA	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-sequence	NULL
probe	NULL
.	NULL

Open	NULL
arrow	NULL
indicates	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
complex	NULL
;	NULL
solid	NULL
arrow	NULL
indicates	NULL
the	NULL
TPA-induced	NULL
complex	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
A23187	NULL
and	NULL
TPA	NULL
were	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
unlabeled	NULL
oligonucleotides	NULL
before	NULL
addition	NULL
of	NULL
a	NULL
P-sequence	NULL
probe	NULL
.	NULL

HMC	NULL
,	NULL
high-mobility	NULL
complex	NULL
(	NULL
see	NULL
text	NULL
)	NULL
;	NULL
n.s	NULL
.	NULL

,	NULL
nonspecific	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Extracts	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
as	NULL
in	NULL
B	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
antisera	NULL
(	NULL
«	NULL
-	NULL
,	NULL
lanes	NULL
2-5	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
P.S	NULL
.	NULL

,	NULL
lane	NULL
1	NULL
)	NULL
after	NULL
addition	NULL
of	NULL
a	NULL
P-sequence	NULL
probe	NULL
.	NULL

«	NULL
,	NULL
Anti	NULL
.	NULL

formed	NULL
on	NULL
either	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
their	NULL
relative	NULL
intensities	NULL
indicated	NULL
preferential	NULL
NF-AT	NULL
binding	NULL
to	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
and	NULL
preferential	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
Scatchard	NULL
analysis	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
RelA	NULL
and	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
to	NULL
the	NULL
two	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
P	NULL
sequence	NULL
is	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
a	NULL
higher-affinity	NULL
binding	NULL
site	NULL
for	NULL
NF-AT	NULL
,	NULL
(	NULL
K4	NULL
=	NULL
128	NULL
pM	NULL
)	NULL
and	NULL
a	NULL
lower-affinity	NULL
site	NULL
for	NULL
RelA	NULL
(	NULL
Kq	NULL
=	NULL
526	NULL
pM	NULL
)	NULL
than	NULL
its	NULL
human	NULL
counterpart	NULL
(	NULL
K4	NULL
=	NULL
535	NULL
and	NULL
116	NULL
pM	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

NF-B	NULL
Overexpression	NULL
and	NULL
PKC	NULL
Stimulation	NULL
Do	NULL
Not	NULL
Suppress	NULL
the	NULL
Activity	NULL
of	NULL
a	NULL
Mouse	NULL
P	NULL
Sequence-Containing	NULL
IL4	NULL
Promoter	NULL
.	NULL

The	NULL
affinities	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
P	NULL
sequences	NULL
for	NULL
NF-AT	NULL
,	NULL
and	NULL
RelA	NULL
account	NULL
for	NULL
differential	NULL
complex	NULL
display	NULL
in	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Recombinant	NULL
RelA	NULL
was	NULL
unable	NULL
to	NULL
displace	NULL
NF-AT	NULL
,	NULL
from	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
mouse	NULL
P	NULL
A	NULL
3	NULL
1	NULL
C	NULL
Control	NULL
E	NULL
TNF-	NULL
«	NULL
&	NULL
&	NULL
A23187	NULL
6	NULL
3	NULL
A23187/	NULL
``	NULL
g	NULL
2	NULL
TNF-	NULL
«	NULL
g	NULL
D	NULL
R	NULL
NFKB1	NULL
_	NULL
-	NULL
+	NULL
+	NULL
3	NULL
it	NULL
+	NULL
4	NULL
J-C	NULL
RelA	NULL
--	NULL
-M	NULL
-	NULL
_	NULL
~~	NULL
,	NULL
m	NULL
o	NULL
-	NULL
§	NULL
talin	NULL
IL-2	NULL
15ACX	NULL
pIL-4.306	NULL
a	NULL
\-	NULL
«	NULL
blind	NULL
i	NULL
sat	NULL
pa	NULL
burg	NULL
=	NULL
>	NULL
250	NULL
C	NULL
]	NULL
Control	NULL
NF-AT	NULL
,	NULL
rath	NULL
vcs	NULL
es	NULL
mp	NULL
>	NULL
-	NULL
qnpbtmad	NULL
Percent	NULL
of	NULL
Control	NULL
A	NULL
mE	NULL
?	NULL

150	NULL
|	NULL
100	NULL
50	NULL
{	NULL
I	NULL
Fi	NULL
S	NULL
a	NULL
Free	NULL
|	NULL
awe	NULL
-	NULL
Free	NULL
u	NULL
NFKB1	NULL
(	NULL
ug	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
``	NULL
2	NULL
.	NULL

8	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Downregulation	NULL
of	NULL
IL4	NULL
promoter	NULL
activity	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
IL-2.15ACX	NULL
or	NULL
pIL-4.306	NULL
reporter	NULL
plasmid	NULL
and	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
and/or	NULL
A23187	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
fold	NULL
induction	NULL
in	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
pIL-4.306	NULL
reporter	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
1	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
a	NULL
RelA	NULL
and/or	NULL
an	NULL
NFKB1	NULL
expression	NULL
plasmid	NULL
;	NULL
then	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
A23187	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
percent	NULL
of	NULL
controls-i.e	NULL
.	NULL

,	NULL
CAT	NULL
activity	NULL
in	NULL
cells	NULL
cotransfected	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
noncoding	NULL
plasmids-in	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
C	NULL
)	NULL
P-sequence	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
a	NULL
constant	NULL
amount	NULL
(	NULL
~50	NULL
ng	NULL
)	NULL
of	NULL
recombinant	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
(	NULL
``	NULL
NF-ATp	NULL
``	NULL
)	NULL
and	NULL
various	NULL
amounts	NULL
(	NULL
10	NULL
,	NULL
20	NULL
,	NULL
50	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
)	NULL
of	NULL
recombinant	NULL
RelA	NULL
.	NULL

The	NULL
open	NULL
arrow	NULL
and	NULL
the	NULL
solid	NULL
arrow	NULL
indicate	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
RelA	NULL
monomers	NULL
and	NULL
dimers	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Similar	NULL
experiment	NULL
using	NULL
equivalent	NULL
amounts	NULL
(	NULL
~50	NULL
ng	NULL
)	NULL
of	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
and/or	NULL
NFKB1	NULL
.	NULL

The	NULL
open	NULL
arrow	NULL
and	NULL
the	NULL
solid	NULL
arrow	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
complexes	NULL
formed	NULL
by	NULL
NFKB1	NULL
and	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

11626	NULL
-	NULL
Immunology	NULL
:	NULL
Casolaro	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
A	NULL
GGGAAATTCC	NULL
PRD-1I	NULL
CAAATTTTCC	NULL
distal	NULL
NF-AT	NULL
2.5	NULL
0.75	NULL
e	NULL
e	NULL
e	NULL
-	NULL
o	NULL
o	NULL
o	NULL
o	NULL
e	NULL
e	NULL
o	NULL
o	NULL
o	NULL
GAAAATTTCC	NULL
AAAATTTTCC	NULL
a	NULL
e	NULL
huP	NULL
®	NULL
000	NULL
00	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
2.0	NULL
{	NULL
o	NULL
muP	NULL
y	NULL
=	NULL
1.64	NULL
-	NULL
0.0086x	NULL
|-	NULL
0.60	NULL
human	NULL
P	NULL
sequence	NULL
mouse	NULL
P	NULL
sequence	NULL
4	NULL
y	NULL
=	NULL
2.05	NULL
-	NULL
0.0078x	NULL
1.5	NULL
q	NULL
|-	NULL
0.45	NULL
1.0	NULL
4	NULL
|-	NULL
0.30	NULL
OMOHW	NULL
.	NULL

0.5	NULL
]	NULL
y=0.34	NULL
-	NULL
0.0019	NULL
%	NULL
-o.1s	NULL
Bound/Free	NULL
DNA	NULL
Ratio	NULL
C	NULL
&	NULL
``	NULL
.	NULL

“	NULL
2	NULL
.	NULL

NF-AT	NULL
,	NULL
|	NULL
RelA	NULL
_	NULL
y=044-	NULL
00019	NULL
0	NULL
y	NULL
r	NULL
-~	NULL
r	NULL
t	NULL
r	NULL
0	NULL
0	NULL
50	NULL
100	NULL
150	NULL
200	NULL
100	NULL
125	NULL
150	NULL
175	NULL
200	NULL
Bound	NULL
DNA	NULL
(	NULL
pM	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
mouse	NULL
P	NULL
sequence	NULL
as	NULL
a	NULL
lower-affinity	NULL
binding	NULL
site	NULL
for	NULL
RelA	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
P	NULL
sequences	NULL
with	NULL
known	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NF-AT	NULL
sites	NULL
.	NULL

Base	NULL
identities	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
positive	NULL
regulatory	NULL
domain	NULL
II	NULL
,	NULL
PRD-II	NULL
)	NULL
or	NULL
NF-AT	NULL
(	NULL
distal	NULL
NF-AT	NULL
;	NULL
see	NULL
text	NULL
)	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
@	NULL
or	NULL
O	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
A23187	NULL
and	NULL
TPA	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
antisera	NULL
(	NULL
a-	NULL
,	NULL
lanes	NULL
2-4	NULL
and	NULL
6-8	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
P.S	NULL
.	NULL

,	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
after	NULL
addition	NULL
of	NULL
a	NULL
mouse	NULL
(	NULL
muP	NULL
)	NULL
or	NULL
a	NULL
human	NULL
(	NULL
huP	NULL
)	NULL
P-sequence	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Scatchard	NULL
analysis	NULL
of	NULL
EMSAs	NULL
using	NULL
constant	NULL
amounts	NULL
of	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
(	NULL
``	NULL
NF-AT	NULL
,	NULL
``	NULL
,	NULL
~20	NULL
ng	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
~100	NULL
ng	NULL
)	NULL
and	NULL
various	NULL
concentrations	NULL
(	NULL
0.05-0.5	NULL
nM	NULL
for	NULL
NF-AT	NULL
,	NULL
and	NULL
0.1-1	NULL
nM	NULL
for	NULL
RelA	NULL
)	NULL
of	NULL
a	NULL
human	NULL
or	NULL
mouse	NULL
P-sequence	NULL
probe	NULL
.	NULL

K4	NULL
values	NULL
(	NULL
see	NULL
text	NULL
)	NULL
were	NULL
calculated	NULL
from	NULL
the	NULL
equations	NULL
shown	NULL
and	NULL
are	NULL
the	NULL
inverse	NULL
reciprocals	NULL
of	NULL
the	NULL
slopes	NULL
.	NULL

sequence	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
characterized	NULL
as	NULL
an	NULL
NF-AT	NULL
,	NULL
binding	NULL
site	NULL
that	NULL
,	NULL
unlike	NULL
the	NULL
IL2	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
human	NULL
IL4	NULL
reporter	NULL
construct	NULL
pIL-	NULL
NF-AT	NULL
sites	NULL
(	NULL
13	NULL
)	NULL
,	NULL
does	NULL
not	NULL
bind	NULL
this	NULL
factor	NULL
as	NULL
a	NULL
complex	NULL
with	NULL
4.85	NULL
(	NULL
huP	NULL
)	NULL
was	NULL
altered	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
generate	NULL
AP-1	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
explains	NULL
why	NULL
Ca*+-dependent	NULL
activation	NULL
of	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
,	NULL
where	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
was	NULL
converted	NULL
to	NULL
NF-AT	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
maximal	NULL
ZL	NULL
4	NULL
promoter	NULL
activity	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
in	NULL
an	NULL
otherwise	NULL
isogenic	NULL
plasmid	NULL
.	NULL

As	NULL
21	NULL
)	NULL
,	NULL
whereas	NULL
PKC	NULL
stimulation	NULL
is	NULL
also	NULL
required	NULL
for	NULL
IL2	NULL
tran-expected	NULL
,	NULL
transcriptional	NULL
activation	NULL
of	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
was	NULL
scriptional	NULL
activation	NULL
(	NULL
4	NULL
,	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
AP-1	NULL
proteins	NULL
can	NULL
consistently	NULL
less	NULL
sensitive	NULL
than	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
to	NULL
RelA	NULL
overex-	NULL
interact	NULL
with	NULL
critical	NULL
elements	NULL
in	NULL
the	NULL
mouse	NULL
ZL4	NULL
promoter	NULL
(	NULL
21	NULL
,	NULL
pression	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
and	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
PKC	NULL
stimulation	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
that	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
can	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

cooperatively	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
driven	NULL
by	NULL
composite	NULL
OAP4p/P	NULL
sequence	NULL
repeats	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
provide	NULL
a	NULL
second	NULL
expla-DISCUSSION	NULL
nation	NULL
for	NULL
differential	NULL
signaling	NULL
requirements	NULL
for	NULL
IL2	NULL
and	NULL
IL4	NULL
Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PKC	NULL
stimulation	NULL
on	NULL
expression	NULL
in	NULL
Ty	NULL
cells	NULL
and	NULL
suggest	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
component	NULL
IL4	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
7	NULL
)	NULL
is	NULL
exerted	NULL
at	NULL
the	NULL
RelA	NULL
mediates	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PKC	NULL
activation	NULL
on	NULL
transcriptional	NULL
level	NULL
and	NULL
identify	NULL
the	NULL
P	NULL
sequence	NULL
as	NULL
the	NULL
critical	NULL
human	NULL
IL4	NULL
transcription	NULL
.	NULL

Our	NULL
conclusions	NULL
are	NULL
supported	NULL
by	NULL
element	NULL
mediating	NULL
this	NULL
phenomenon	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
has	NULL
been	NULL
three	NULL
lines	NULL
of	NULL
evidence	NULL
:	NULL
(	NULL
¢	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
induced	NULL
by	NULL
RelA	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
NF.ATp++—++-	NULL
2	NULL
_	NULL
.	NULL

4	NULL
C	NULL
]	NULL
Control	NULL
B	NULL
Percent	NULL
of	NULL
Control	NULL
E	NULL
22211837	NULL
ll	NULL
o	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
walp	NULL
>	NULL
~	NULL
Ae	NULL
andl	NULL
Ave	NULL
de	NULL
lk	NULL
i	NULL
Pek	NULL
3	NULL
-	NULL
TPA	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
C	NULL
Control	NULL
H	NULL
RelA	NULL
Fold	NULL
Induction	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
__	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
RelA	NULL
overexpression	NULL
or	NULL
PKC	NULL
stimulation	NULL
on	NULL
an	NULL
IL4	NULL
promoter	NULL
construct	NULL
containing	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Recombinant	NULL
proteins	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
(	NULL
``	NULL
NF-AT	NULL
,	NULL
``	NULL
,	NULL
20	NULL
ng	NULL
)	NULL
and/or	NULL
RelA	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
mouse	NULL
(	NULL
muP	NULL
)	NULL
or	NULL
human	NULL
(	NULL
huP	NULL
)	NULL
P	NULL
sequence	NULL
probes	NULL
.	NULL

The	NULL
open	NULL
arrow	NULL
and	NULL
the	NULL
filled	NULL
arrow	NULL
indicate	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
RelA	NULL
and	NULL
by	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Reporter	NULL
plasmid	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
or	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
(	NULL
see	NULL
text	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ug	NULL
of	NULL
a	NULL
RelA	NULL
expression	NULL
plasmid	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
percent	NULL
of	NULL
control	NULL
CAT	NULL
activity	NULL
in	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
pIL-4.85	NULL
(	NULL
huP	NULL
)	NULL
or	NULL
pIL-4.85	NULL
(	NULL
muP	NULL
)	NULL
reporter	NULL
plasmid	NULL
and	NULL
stimulated	NULL
with	NULL
A23187	NULL
and/or	NULL
TPA	NULL
.	NULL

Bars	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
fold	NULL
induction	NULL
in	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

Immunology	NULL
:	NULL
Casolaro	NULL
et	NULL
al	NULL
.	NULL

PKC	NULL
stimulation	NULL
(	NULL
22	NULL
)	NULL
bind	NULL
to	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
with	NULL
higher	NULL
affinity	NULL
than	NULL
NF-AT	NULL
,	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
4	NULL
)	NULL
;	NULL
(	NULL
i	NULL
)	NULL
RelA	NULL
represses	NULL
human	NULL
IL4	NULL
promoter	NULL
activity	NULL
and	NULL
displaces	NULL
NF-AT	NULL
,	NULL
from	NULL
complexes	NULL
formed	NULL
on	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
;	NULL
and	NULL
(	NULL
#	NULL
?	NULL
)	NULL

replacement	NULL
of	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
with	NULL
a	NULL
site	NULL
binding	NULL
RelA	NULL
with	NULL
lower	NULL
affinity	NULL
and	NULL
NF-AT	NULL
,	NULL
with	NULL
higher	NULL
affinity	NULL
,	NULL
such	NULL
as	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
abrogates	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PKC	NULL
stimulation	NULL
on	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

We	NULL
define	NULL
the	NULL
P	NULL
sequence	NULL
as	NULL
a	NULL
shared	NULL
binding	NULL
site	NULL
for	NULL
NF-AT	NULL
and	NULL
Rel	NULL
family	NULL
members	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
human	NULL
P	NULL
sequence	NULL
(	NULL
14	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NF-AT-like	NULL
proteins	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
has	NULL
been	NULL
described	NULL
as	NULL
well	NULL
(	NULL
8	NULL
,	NULL
32	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
inasmuch	NULL
as	NULL
the	NULL
core	NULL
NF-AT	NULL
,	NULL
-binding	NULL
GGAA	NULL
tetranucleotide	NULL
(	NULL
8	NULL
,	NULL
29	NULL
)	NULL
is	NULL
also	NULL
part	NULL
of	NULL
most	NULL
NF-kB	NULL
sites	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
different	NULL
NF-AT	NULL
and	NULL
Rel	NULL
family	NULL
members	NULL
are	NULL
highly	NULL
related	NULL
(	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

We	NULL
identified	NULL
critical	NULL
base	NULL
divergences	NULL
in	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
P	NULL
sequences	NULL
that	NULL
account	NULL
for	NULL
preferential	NULL
NF-AT	NULL
,	NULL
or	NULL
RelA	NULL
binding	NULL
when	NULL
both	NULL
factors	NULL
are	NULL
activated	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
RelA	NULL
can	NULL
compete	NULL
with	NULL
NF-AT	NULL
,	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
,	NULL
but	NULL
not	NULL
mouse	NULL
,	NULL
P	NULL
sequence	NULL
.	NULL

Although	NULL
our	NULL
findings	NULL
do	NULL
not	NULL
support	NULL
a	NULL
direct	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
mouse	NULL
IL4	NULL
transcription	NULL
,	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
formation	NULL
on	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
inhibition	NULL
of	NULL
promoter	NULL
constructs	NULL
containing	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
in	NULL
RelA-overexpressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
imply	NULL
that	NULL
additional	NULL
factors	NULL
may	NULL
promote	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
an	NULL
otherwise	NULL
low-affinity	NULL
site	NULL
under	NULL
some	NULL
circumstances	NULL
in	NULL
vivo	NULL
.	NULL

One	NULL
possible	NULL
candidate	NULL
is	NULL
the	NULL
chromosomal	NULL
protein	NULL
high-mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
which	NULL
enhances	NULL
interferon	NULL
B	NULL
promoter	NULL
activity	NULL
by	NULL
favoring	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
PRD-II	NULL
site	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
view	NULL
,	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
and	NULL
downregulate	NULL
mouse	NULL
IL4	NULL
promoter	NULL
activity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Two	NULL
Rel	NULL
family	NULL
members	NULL
exert	NULL
opposite	NULL
effects	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
ZL2	NULL
and	NULL
IL4	NULL
transcription	NULL
.	NULL

Remarkably	NULL
,	NULL
RelA	NULL
,	NULL
a	NULL
general	NULL
transcriptional	NULL
activator	NULL
(	NULL
27	NULL
)	NULL
,	NULL
acts	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
human	NULL
IL4	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
it	NULL
plays	NULL
a	NULL
permissive	NULL
role	NULL
in	NULL
IL2	NULL
transcription	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
NFKB1	NULL
,	NULL
which	NULL
reportedly	NULL
represses	NULL
IL	NULL
2	NULL
promoter	NULL
activity	NULL
(	NULL
33	NULL
)	NULL
,	NULL
is	NULL
an	NULL
IL4	NULL
promoter	NULL
activator	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
NFKB1	NULL
ho-modimers	NULL
,	NULL
with	NULL
decreased	NULL
formation	NULL
of	NULL
RelA-NFKB1	NULL
het-erodimers	NULL
,	NULL
occurs	NULL
upon	NULL
induction	NULL
of	NULL
cellular	NULL
tolerance	NULL
in	NULL
vitro	NULL
(	NULL
34	NULL
)	NULL
.	NULL

T-cell	NULL
tolerance	NULL
in	NULL
vivo	NULL
is	NULL
accompanied	NULL
by	NULL
preferential	NULL
IL4	NULL
expression	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
cAMP	NULL
accumulation	NULL
in	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
increased	NULL
expression	NULL
of	NULL
Ty2-related	NULL
lymphokines	NULL
and	NULL
decreased	NULL
IL2	NULL
expression	NULL
,	NULL
as	NULL
well	NULL
as	NULL
decreased	NULL
RelA	NULL
activation	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
IL2	NULL
transcription	NULL
in	NULL
mouse	NULL
Ty2	NULL
clones	NULL
has	NULL
been	NULL
related	NULL
to	NULL
the	NULL
failure	NULL
to	NULL
generate	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
this	NULL
phenomenon	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
derepression	NULL
of	NULL
IL4	NULL
and	NULL
other	NULL
Ty2-related	NULL
genes	NULL
and	NULL
indicate	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
a	NULL
possible	NULL
mediator	NULL
of	NULL
mutually	NULL
exclusive	NULL
IL-2	NULL
and	NULL
IL-4	NULL
synthesis	NULL
in	NULL
Ty	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

L.	NULL
M.	NULL
Lichtenstein	NULL
and	NULL
T.	NULL
Maniatis	NULL
for	NULL
their	NULL
encour-agement	NULL
;	NULL
Drs	NULL
.	NULL

G.	NULL
R.	NULL
Crabtree	NULL
and	NULL
A.	NULL
Rao	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
reagents	NULL
;	NULL
and	NULL
Drs	NULL
.	NULL

K.	NULL
Ebralidse	NULL
,	NULL
J.	NULL
P.	NULL
Schneck	NULL
,	NULL
J.	NULL
T.	NULL
Schroeder	NULL
,	NULL
and	NULL
C.	NULL
Stellato	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
S.J.0	NULL
.	NULL

and	NULL
S.N.G	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
S.J.0	NULL
.	NULL

and	NULL
S.A.A	NULL
.	NULL
)	NULL

,	NULL
and	NULL
Hoffmann-LaRoche	NULL
Pharmaceutical	NULL
Corporation	NULL
(	NULL
S.J.0	NULL
.	NULL
)	NULL

.	NULL

V.C	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Public	NULL
Health	NULL
Service-Fogarty	NULL
International	NULL
Center	NULL
and	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Marion-Merrell	NULL
Dow	NULL
Scholar	NULL
in	NULL
Allergy	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Academy	NULL
of	NULL
Asthma	NULL
,	NULL
Allergy	NULL
,	NULL
and	NULL
Immunology	NULL
.	NULL

1	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
&	NULL
Coffman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
145-173	NULL
.	NULL

>	NULL
wb	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
-	NULL
11627	NULL
Romagnani	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
12	NULL
,	NULL
256-257	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
&	NULL
Seder	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
241-251	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
&	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
1045-1083	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
Zubiaga	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Mufioz	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Huber	NULL
,	NULL
B.	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
Regul	NULL
.	NULL

1	NULL
,	NULL
425-434	NULL
.	NULL

Tamura	NULL
,	NULL
T.	NULL
,	NULL
Yanagida	NULL
,	NULL
T.	NULL
&	NULL
Nariuchi	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6051-6061	NULL
.	NULL

Van	NULL
der	NULL
Pouw-Kraan	NULL
,	NULL
T.	NULL
,	NULL
Van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
Rensink	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Aarden	NULL
,	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
1237-1241	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Bel-agaje	NULL
,	NULL
R.	NULL
&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
625-633	NULL
.	NULL

Kubo	NULL
,	NULL
M.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
&	NULL
Ransom	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
19441-19446	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Miner	NULL
,	NULL
Z.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
&	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
352-355	NULL
.	NULL

Abe	NULL
,	NULL
E.	NULL
,	NULL
De	NULL
Waal-Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Matsuda	NULL
,	NULL
L.	NULL
,	NULL
Arai	NULL
,	NULL
K.-I	NULL
.	NULL

&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
2864-2868	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
777-789	NULL
.	NULL

Ono	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
BaZil	NULL
,	NULL
V.	NULL
,	NULL
Sugawara	NULL
,	NULL
M.	NULL
&	NULL
Strominger	NULL
,	NULL
J	NULL
;	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173	NULL
,	NULL
629-637	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
Ross	NULL
,	NULL
J.	NULL
,	NULL
Scheppler	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1883-1893	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
&	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
4138-4145	NULL
.	NULL

Tara	NULL
,	NULL
D.	NULL
,	NULL
Weiss	NULL
,	NULL
D.	NULL
L.	NULL
&	NULL
Brown	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
3617-3626	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
775-787	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gold	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Murphy	NULL
,	NULL
T.	NULL
L.	NULL
&	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4793-4805	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1455-1460	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Saito	NULL
,	NULL
F.	NULL
,	NULL
Hannum	NULL
,	NULL
C.	NULL
,	NULL
Arai	NULL
,	NULL
K.-I	NULL
.	NULL

&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2697-2706	NULL
.	NULL

Matsuda	NULL
,	NULL
I.	NULL
,	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Behnam	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

199	NULL
,	NULL
439-446	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
J.-S.	NULL
&	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143	NULL
,	NULL
1-62	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
287-294	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Schomberg	NULL
,	NULL
C.	NULL
,	NULL
Gerwig	NULL
,	NULL
R.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
,	NULL
Grumimt	NULL
,	NULL
F.	NULL
&	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5694-5704	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hoey	NULL
,	NULL
T.	NULL
&	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
473-483	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Jamieson	NULL
,	NULL
C.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
&	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
1864-1871	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
Tran	NULL
,	NULL
A.-C.	NULL
,	NULL
Grilli	NULL
,	NULL
M.	NULL
&	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
1452-1456	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schraut	NULL
,	NULL
W.	NULL
,	NULL
Strobel	NULL
,	NULL
M.	NULL
,	NULL
Wendelgass	NULL
,	NULL
P.	NULL
,	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Bauerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
&	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
17001-17004	NULL
.	NULL

Vidard	NULL
,	NULL
L.	NULL
,	NULL
Colarusso	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

&	NULL
Benacerraf	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
2259-2262	NULL
.	NULL

Neumann	NULL
,	NULL
M.	NULL
,	NULL
Grieshammer	NULL
,	NULL
T.	NULL
,	NULL
Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Kneitz	NULL
,	NULL
B.	NULL
,	NULL
Lohoff	NULL
,	NULL
M.	NULL
,	NULL
Schimpl	NULL
,	NULL
A.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1991-2004	NULL
.	NULL

Lederer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Liou	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
&	NULL
Lichtman	NULL
,	NULL
A.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
77-86	NULL
.	NULL

